Concurrent occurrence of ulcerative duodenitis and ulcerative colitis displaying unique responses to golimumab and ustekinumab

Le Berre C, Honap S, Peyrin-Biroulet L. Ulcerative colitis. Lancet. 2023;402:571–84.

Article  PubMed  Google Scholar 

Watanabe T, Minaga K, Kamata K, et al. RICK/RIP2 is a NOD2-independent nodal point of gut inflammation. Int Immunol. 2019;31:669–83.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Masuta Y, Minaga K, Kurimoto M, et al. Activation of nucleotide-binding oligomerization domain 2 by muramyl dipeptide negatively regulates toll-like receptor 9-mediated colonic inflammation through the induction of deubiquitinating enzyme a expression. Int Immunol. 2023;35:79–94.

Article  CAS  PubMed  Google Scholar 

Hori K, Ikeuchi H, Nakano H, et al. Gastroduodenitis associated with ulcerative colitis. J Gastroenterol. 2008;43:193–201.

Article  PubMed  Google Scholar 

Sun Y, Zhang Z, Zheng CQ, et al. Mucosal lesions of the upper gastrointestinal tract in patients with ulcerative colitis: a review. World J Gastroenterol. 2021;27:2963–78.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Schett G, McInnes IB, Neurath MF. Reframing immune-mediated inflammatory diseases through signature cytokine hubs. N Engl J Med. 2021;385:628–39.

Article  CAS  PubMed  Google Scholar 

Masaki S, Watanabe T, Arai Y, et al. Expression levels of cellular inhibitor of apoptosis proteins and colitogenic cytokines are inversely correlated with the activation of interferon regulatory factor 4. Clin Exp Immunol. 2022;207:340–50.

Article  PubMed  PubMed Central  Google Scholar 

Hisabe T, Matsui T, Miyaoka M, et al. Diagnosis and clinical course of ulcerative gastroduodenal lesion associated with ulcerative colitis: possible relationship with pouchitis. Dig Endosc. 2010;22:268–74.

Article  PubMed  Google Scholar 

Li M, Liu Y, Cui J, et al. Ulcerative colitis with mucosal lesions in duodenum: two case reports. Medicine (Baltimore). 2019;98: e15035.

Article  PubMed  Google Scholar 

Valdez R, Appelman HD, Bronner MP, et al. Diffuse duodenitis associated with ulcerative colitis. Am J Surg Pathol. 2000;24:1407–13.

Article  CAS  PubMed  Google Scholar 

Hayashi T, Terashima T, Nishitani M, et al. Gastroduodenitis Associated with active ulcerative colitis treated with infliximab: different clinical course in the colon and gastroduodenal lesions. Intern Med. 2024;63:929–35.

Article  PubMed  Google Scholar 

Chiba M, Ono I, Wakamatsu H, et al. Diffuse gastroduodenitis associated with ulcerative colitis: treatment by infliximab. Dig Endosc. 2013;25:622–5.

Article  PubMed  Google Scholar 

Akitake R, Nakase H, Tamaoki M, et al. Modulation of Th1/Th2 balance by infliximab rescues postoperative occurrence of small-intestinal inflammation associated with ulcerative colitis. Dig Dis Sci. 2010;55:1781–4.

Article  PubMed  Google Scholar 

Choi YS, Kim JK, Kim WJ, et al. Remission of diffuse ulcerative duodenitis in a patient with ulcerative colitis after infliximab therapy: a case study and review of the literature. Intest Res. 2019;17:273–7.

Article  PubMed  PubMed Central  Google Scholar 

Willington AJ, Taylor G, White J, et al. Gastrointestinal: ulcerative colitis-associated duodenitis. J Gastroenterol Hepatol. 2018;33:973.

Article  CAS  PubMed  Google Scholar 

Neurath MF. Cytokines in inflammatory bowel disease. Nat Rev Immunol. 2014;14:329–42.

Article  CAS  PubMed  Google Scholar 

留言 (0)

沒有登入
gif